Changing reimbursement climate for biosimilars
[View][Edit][Delete][Dev load][Dev render][Edit type][Manage fields][Display fields]Creating compelling content and personal connections for the Life Science industry for nearly two decades.CBI, a division of UBM Americas, is the life sciences industry leader in providing thought leadership, actionable data, benchmarking, case studies and regulatory information through a dynamic conference platform that facilitates innovation, collaboration and elevation across the pharmaceutical, biotechnology, medical device and healthcare industries. CBI’s proprietary and intensive market research and product feasibility testing methodology has helped CBI deliver timely and first to market content driven conferences. These include annual flag ship events such as PCC (Pharmaceutical Compliance Congress), PAP (Patient Assistance and Access Programs), Pharma Accounting and Reporting Congress, Pharma Forum and Medicaid and Government Pricing Congress. Benefiting over 5,000 executives annually, CBI conferences provide the market with leading edge, actionable information on the most compelling industry mega and micro trends through exclusive thought leadership presentations from our esteemed speaking faculty and government officials. CBI conferences also serve to connect executives and decision makers with technology, regulatory and consulting solutions from Fortune 500 companies and the most cutting edge solution providers.
Leverage Visualization Tools to Strengthen Compliance Programs and Business Intelligence
The Bio/Pharma Contact Centers Conference serves as the gold standard event for those responsible for bio/pharma call center strategy and management. This program provides a unique opportunity to benchmark...